Navigation Links
VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer
Date:7/3/2011

Meyer on July 7, 2011 from 9:30am-12:30pm CEST.  

The IASLC's 14th World Conference on Lung Cancer is being held in Amsterdam, the Netherlands from July 3-July 7, 2011.  For more information, visit www.2011worldlungcancer.org/

About the International Association for the Study of Lung Cancer (IASLC)Founded in 1972, the International Association for the Study of Lung Cancer (IASLC) is an international organization of nearly 3,000 lung cancer specialists spanning 80 countries. IASLC members work towards developing and promoting the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and other thoracic malignancies. IASLC's mission is to enhance the understanding and education of lung cancer to scientists, members of the medical community and the public. In addition to the biannual meeting, the IASLC publishes the Journal of Thoracic Oncology, a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

About VisionGateVisionGate, Inc. is developing a revolutionary non-invasive test for the early detection of lung cancer, using its automated 3D cell imaging platform, the Cell-CT™, which generates high-resolution 3D biosignatures from intact cells using a sputum sample.  The company's LuCED™ test is initially being developed for adjunctive use with low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.  Adjunctive use of LuCED to better manage the high rate of false positive results in CT screening could increase the utility and cost effectiveness of the approach, which has been shown to decrease lung cancer deaths in former and current smokers.  For more information, visit www.visiongate3D.com.VisionGate  

MediaScarlett
'/>"/>

SOURCE VisionGate, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
2. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
3. Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011
4. Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
5. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
6. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
7. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
8. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
9. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, ... scientific poster describing an innovative diagnostic procedure for the ... New Light on Disease (SPEC) conference in Krakow, ... poster entitled, "Development of in vitro Diagnostics for Detection ... discussed during the conference poster session on Tuesday, August ...
(Date:8/19/2014)... Aug. 19, 2014  As power morcellator lawsuits ... Bernstein Liebhard LLP notes that women in need ... a number of options that do not involve ... According to a report published by The Wall ... options include a mini-laparotomy and vaginal hysterectomy. Non-surgical ...
(Date:8/19/2014)... -- Research and Markets has announced the addition ... Business Report" report to their offering. ... Drugs in US$ Million by the following Brands: Humatrope, Norditropin, ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of World. ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
... Dec. 16 Vivakor, Inc. (OTC Bulletin Board: VIVK) ... out of Walnut Creek, California and its affiliate group, ... Consulting has been retained by Vivakor to assist with ... recently reported acquisition strategy. Specifically, Baker Consulting is exploring ...
... , EVANSTON, Ill., Dec. ... innovative treatments for depression and other CNS disorders based on ... presented at a major medical meeting showed that its lead ... signs of the CNS-related side effects seen with other drugs ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6
(Date:8/20/2014)... Aug. 20, 2014 A common approach to treating ... did not improve survival chances for people who suddenly ... at the University of Pittsburgh School of Medicine. , ... One , suggest acute hemodialysis, an aggressive method that ... may not provide a definitive benefit to the patient. ...
(Date:8/20/2014)... a novel approach to treating cancer - using Botox. ... Science Translational Medicine shows that cancer growth ... nerves that are linked to cancer stem cells. The ... made the treatment cheap, safe and efficient. The researchers ... will soon start testing on humans. , The nervous ...
(Date:8/20/2014)... A common approach to treating kidney failure ... improve survival chances for people who suddenly developed the ... University of Pittsburgh School of Medicine. ... PLOS One , suggest acute hemodialysis, an aggressive ... kidney failure, may not provide a definitive benefit to ...
(Date:8/20/2014)... 2014 (HealthDay News) -- New research reveals that, long ... the global spread of the infectious disease known as ... in Africa to seals and sea lions, who then ... years ago, according to an international team of researchers. ... rise again worldwide. This study and further research will ...
(Date:8/20/2014)... August 20, 2014 Get the report ... with mergermarket presents “Deal Drivers 2014 Half Year Report ... of M&A activity in both North and South America, ... , About Merrill DataSite     , Merrill DataSite is a ... optimises the due diligence process by providing a highly ...
Breaking Medicine News(10 mins):Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Treating gastric cancer -- with Botox 2Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2Health News:Register to Download Merrill DataSite's Report: Deal Drivers 2014 Half Year Report for the Americas 2
... , In an observational cohort study from ... on prevention of mother-to-child HIV transmission among women ... recommendations. , Citation: Tonwe-Gold B, Ekouevi DK, Viho ... Antiretroviral treatment and prevention of peripartum and postnatal ...
... a key gene might not be to blame, researchers say ... is poking holes in a prevailing theory on the origins ... to rein in cell-damaging free radicals actually had fewer ... "This finding may go beyond Alzheimer,s into all aging theory," ...
... in no real danger, survey finds , MONDAY, Aug. 20 ... white peers to take risks that boost their odds for ... August issue of the journal Archives of Dermatology , ... Medicine surveyed 369 high school students (221 white Hispanics and ...
... Compared with Caucasians, African-Americans are exposed to more ... of Medicine study published in this months Public Health ... preventable death and disease in the United States, causing ... $150 billion in direct and indirect costs each year; ...
... study likely applicable to men of other ethnicities, Tulane ... drinks per week) may increase the risk of stroke ... published in the latest issue of Annals of Neurology. ... of Tulane University School of Public Health and Tropical ...
... 2007 - Lissamine green sounds like the latest cleaning ... you would want to get in your eyes. , ... patterns that are key to diagnosing dry eye syndrome ... treating the potentially sight-stealing disease, new research at UT ...
Cached Medicine News:Health News:HIV therapy in pregnancy-data support WHO recommendations 2Health News:Study Puts 1 Alzheimer's Theory in Doubt 2Health News:Study Puts 1 Alzheimer's Theory in Doubt 3Health News:Hispanic Teens Take More Skin Cancer Risks 2Health News:Pitt study finds inequality in tobacco advertising 2Health News:Eye-staining technique offers early detection for dry eye syndrome 2Health News:Eye-staining technique offers early detection for dry eye syndrome 3
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... a broad selection of tip ... wide variety of ophthalmic procedures. ... packaged sterile, complete with a ... in the "off " position ...
... Accu-Temp® Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
Medicine Products: